Opisomat 50 Tablet contains Opipramol 50 mg, a tricyclic antidepressant primarily indicated for the treatment of anxiety disorders, psychosomatic conditions, and depressive episodes. Opipramol exerts its therapeutic effects by modulating neurotransmitter activity in the central nervous system, particularly through sigma receptor agonism, which contributes to its anxiolytic and antidepressant properties without significant anticholinergic side effects commonly seen with other tricyclic agents. This medication is prescribed to alleviate symptoms such as persistent anxiety, tension, and somatic complaints associated with psychological stress. Opisomat 50 is typically administered orally, with dosage tailored to the individual patient’s clinical condition and response to therapy. Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances, although it is generally well tolerated. Caution is advised in patients with a history of cardiac disorders, glaucoma, or epilepsy. Use during pregnancy and lactation should be under strict medical supervision. Due to its sedative potential, patients are advised to avoid driving or operating heavy machinery until they understand how the medication affects them. Regular follow-up is essential to monitor therapeutic efficacy and any adverse reactions. Opisomat 50 should be used as part of a comprehensive treatment plan including psychological support.